Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Explore practical signs you should modify your spending plan and a straightforward approach to refreshing priorities for better outcomes.
22,050 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
A proposed state ban on institutional buyers could change how Californians get loans for homes and how lenders price ...
The idea of Tesla merging with SpaceX has captivated investors and enthusiasts alike. This article breaks down what a...
July 1 brought a sharp move for CoreWeave as a Bloomberg note about Meta expanding into cloud services rattled AI inf...
As allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
Qualcomm is navigating a tough start to 2026. A memory crunch, potential shifts with Apple, and a large buyback are m...
A rising wave of data centers and AI workloads is straining power grids. Learn how a strategic nuclear stock could ri...
When a high-growth fintech faces headwinds, patient investors look for generational buying opportunities. This guide ...
As whispers of an OpenAI IPO grow louder, investors must ask: is openai going public wrong for reasons that could der...
Nuclear energy has moved from niche to core in many energy plans. This guide breaks down the best nuclear energy stoc...
A non-spouse beneficiary can dramatically lower or raise lifetime taxes on an inherited IRA depending on withdrawal t...
A smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...